Prostate Cancer
Novartis Confirms Unconstrained Supply for Pluvicto® and Continues to Significantly Expand the Number of Treatment Centers
October 27, 2023
Robot-Assisted Surgery and Racial and Ethnic Disparities in Post-Prostatectomy Outcomes Among Prostate Cancer Patients.
October 27, 2023
Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer-Combination Strategies.
October 27, 2023
Pelvic irradiation for node-positive prostate cancer after prostatectomy: Long-term results of the prospective PLATIN-4 and PLATIN-5 trials.
October 27, 2023
The long tail of oncogenic drivers in prostate cancer.
October 27, 2023
Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer.
October 27, 2023
Monitoring Intrafraction Motion of the Prostate During Radiation Therapy: Suggested Practice Points from a Focused Review.
October 26, 2023
Overall Survival and Associations of Insurance Status Among Hispanic Men With High-Risk Prostate Cancer.
October 26, 2023
Characteristics of incidental prostate cancer in the United States.
October 25, 2023